These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Efficacy of intravenous lacosamide as an add-on treatment in refractory status epilepticus: a multicentric prospective study. Miró J; Toledo M; Santamarina E; Ricciardi AC; Villanueva V; Pato A; Ruiz J; Juvany R; Falip M Seizure; 2013 Jan; 22(1):77-9. PubMed ID: 23127776 [TBL] [Abstract][Full Text] [Related]
4. Intravenous lacosamide in status epilepticus and seizure clusters. Höfler J; Unterberger I; Dobesberger J; Kuchukhidze G; Walser G; Trinka E Epilepsia; 2011 Oct; 52(10):e148-52. PubMed ID: 21801171 [TBL] [Abstract][Full Text] [Related]
5. Lacosamide in children with refractory status epilepticus. A multicenter Italian experience. Grosso S; Zamponi N; Bartocci A; Cesaroni E; Cappanera S; Di Bartolo R; Balestri P Eur J Paediatr Neurol; 2014 Sep; 18(5):604-8. PubMed ID: 24836405 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of intravenous lacosamide in refractory nonconvulsive status epilepticus and simple partial status epilepticus. Rantsch K; Walter U; Wittstock M; Benecke R; Rösche J Seizure; 2011 Sep; 20(7):529-32. PubMed ID: 21489827 [TBL] [Abstract][Full Text] [Related]
7. Intravenous lacosamide in clinical practice-Results from an independent registry. Lang N; Lange M; Schmitt FC; Bös M; Weber Y; Evers S; Burghaus L; Kellinghaus C; Schubert-Bast S; Bösel J; Lammers T; Sabolek M; van Baalen A; Dziewas R; Kraft A; Ruf S; Stephani U Seizure; 2016 Jul; 39():5-9. PubMed ID: 27161669 [TBL] [Abstract][Full Text] [Related]
8. Intravenous lacosamide or phenytoin for treatment of refractory status epilepticus. Kellinghaus C; Berning S; Stögbauer F Acta Neurol Scand; 2014 May; 129(5):294-9. PubMed ID: 23937330 [TBL] [Abstract][Full Text] [Related]
9. Single-dose oral lacosamide in refractory simple partial status epilepticus: case report and review. Hawkes MA; Fernández Suárez M; Ugarnes G; D'Giano C Clin Neuropharmacol; 2013; 36(4):138-40. PubMed ID: 23860347 [TBL] [Abstract][Full Text] [Related]
10. Successful treatment for refractory convulsive status epilepticus by non-parenteral lacosamide. Tilz C; Resch R; Hofer T; Eggers C Epilepsia; 2010 Feb; 51(2):316-7. PubMed ID: 19674050 [TBL] [Abstract][Full Text] [Related]
11. Factors influencing response to intravenous lacosamide in emergency situations: LACO-IV study. Garcés M; Villanueva V; Mauri JA; Suller A; García C; López González FJ; Rodríguez Osorio X; Fernández Pajarín G; Piera A; Guillamón E; Santafé C; Castillo A; Giner P; Torres N; Escalza I; Del Villar A; García de Casasola MC; Bonet M; Noé E; Olmedilla N Epilepsy Behav; 2014 Jul; 36():144-52. PubMed ID: 24922617 [TBL] [Abstract][Full Text] [Related]
12. Intravenous lacosamide in seizure emergencies: Observations from a hospitalized in-patient adult population. d'Orsi G; Pascarella MG; Martino T; Carapelle E; Pacillo F; Di Claudio MT; Mancini D; Trivisano M; Avolio C; Specchio LM Seizure; 2016 Nov; 42():20-28. PubMed ID: 27693808 [TBL] [Abstract][Full Text] [Related]
13. Lacosamide as a new treatment option in status epilepticus. Höfler J; Trinka E Epilepsia; 2013 Mar; 54(3):393-404. PubMed ID: 23293881 [TBL] [Abstract][Full Text] [Related]
14. Usefulness of intravenous lacosamide in status epilepticus. Santamarina E; Toledo M; Sueiras M; Raspall M; Ailouti N; Lainez E; Porta I; De Gracia R; Quintana M; Alvarez-Sabín J; Xavier Salas Puig XS J Neurol; 2013 Dec; 260(12):3122-8. PubMed ID: 24122063 [TBL] [Abstract][Full Text] [Related]
15. Comparison of lacosamide versus sodium valproate in status epilepticus: A pilot study. Misra UK; Dubey D; Kalita J Epilepsy Behav; 2017 Nov; 76():110-113. PubMed ID: 28919386 [TBL] [Abstract][Full Text] [Related]
16. Observational study of intravenous lacosamide in patients with convulsive versus non-convulsive status epilepticus. Moreno Morales EY; Fernandez Peleteiro M; Bondy Peña EC; Domínguez Lorenzo JM; Pardellas Santiago E; Fernández A Clin Drug Investig; 2015 Jul; 35(7):463-9. PubMed ID: 26108190 [TBL] [Abstract][Full Text] [Related]
17. Intravenous lacosamide in refractory seizure clusters and status epilepticus: comparison of 200 and 400 mg loading doses. Legros B; Depondt C; Levy-Nogueira M; Ligot N; Mavroudakis N; Naeije G; Gaspard N Neurocrit Care; 2014 Jun; 20(3):484-8. PubMed ID: 23896816 [TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of intravenous lacosamide for adjunctive treatment of refractory status epilepticus: a comparative cohort study. Sutter R; Marsch S; Rüegg S CNS Drugs; 2013 Apr; 27(4):321-9. PubMed ID: 23533010 [TBL] [Abstract][Full Text] [Related]
19. The Safety and Effectiveness of Intravenous Lacosamide for Refractory Status Epilepticus in the Critically Ill. Newey CR; Le NM; Ahrens C; Sahota P; Hantus S Neurocrit Care; 2017 Apr; 26(2):273-279. PubMed ID: 27844464 [TBL] [Abstract][Full Text] [Related]